Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
Journal
Targeted oncology
Journal Volume
17
Journal Issue
3
Date Issued
2022-05
Author(s)
Shimizu, Toshio
Kuboki, Yasutoshi
Yonemori, Kan
Yanai, Tomoko
Faller, Douglas V
Dobler, Lwona
Gupta, Neeraj
Sedarati, Farhad
Kim, Kyu-Pyo
SDGs